# Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹31.52
Day Change: -0.79%
52W High: ₹56.36
52W Low: ₹25.6
Market Cap: ₹52 Cr

## Valuation
P/E: 18.95
P/B: 2.53
EPS: ₹1.7
Book Value: ₹12.74
Dividend Yield: 0%

## Returns
1Y Return: -19.02%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: -93.4%
Profit Growth: -50%
EBITDA Margin: 11.07%
Operating Margin: 11.47%

## About
Biofil Chemicals & Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Biofil Chemicals & Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN, KYC Details, Bank Account Details, Nomination And Other Details.
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN, KYC Details, Bank Account Details, Nomination And Other Details.

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-25T20:00:13.927Z
Price History Updated: 2026-05-25T05:26:22.581Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:26:22.581Z
Quant Updated: 2026-05-25T05:26:22.581Z
Sentiment Updated: 2026-05-25T05:26:22.581Z
Financials Status: current
Financials Updated: 2026-05-18T23:08:23.040Z
Financials Last Attempt: 2026-05-18T23:08:23.040Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹33.4 Cr
Operating Profit: ₹0.47 Cr (OPM 1.41%)
Net Profit: ₹0.56 Cr
Tax: ₹0.18 Cr

## Annual P&L History
FY25: Rev ₹33.4Cr | PAT ₹0.56Cr | OPM 1.41%
FY24: Rev ₹40.04Cr | PAT ₹0.71Cr | OPM 1.05%
FY23: Rev ₹30.04Cr | PAT ₹0.56Cr | OPM 2.46%

## Balance Sheet (FY25)
Total Assets: ₹50.96 Cr
Total Liabilities: ₹32.18 Cr
Borrowings: ₹0.47 Cr
Cash: ₹0.26 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ketan  Shah, MD & Chairman
- Pavan Singh Rajput, Chief Financial Officer
- Joseph  Chacko, Head of Administration
- Apoorv  Jain, Company Secretary & Compliance Officer
- Vinayak  Bhopte, Chief Chemist

---
Source: rupiya.io/stocks/biofilchem
Disclaimer: For research and education only. Not investment advice.